Concepedia

Daniel Holder

DH

Statistics

Publications

57

Citations

6.3K

H-Index

34

Active since

1982

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Novartis (Switzerland)

Pfizer (United States)

Temple University

Daniel Holder is an author at United States Military Academy specializing in life sciences, medicine, and pharmacology.

Publications per year

1982–2021

57

Publications

57

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Roy M. Gulick, John W. Mellors, Diane V. Havlir et al. · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies

Vishal S. Vaidya, Josef Ozer, Frank Dieterle et al. · Nature Biotechnology · 2010 · 650 citations

Medicine, Biochemistry, Nephrology +11

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Jon H. Condra, Daniel Holder, William A. Schleif et al. · Journal of Virology · 1996 · 405 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases

H Wang, Hu Sun, Kimberly Della Penna et al. · Neuroscience · 2002 · 254 citations

Medicine, Neuroscience, Pathobiology +16

Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection

Roy M. Gulick, John W. Mellors, Diane V. Havlir et al. · JAMA · 1998 · 239 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

1–5 of 57